Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study
- PMID: 35725292
- DOI: 10.1136/gutjnl-2022-327504
Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study
Keywords: DIABETES MELLITUS; EPIDEMIOLOGY; LIVER CIRRHOSIS; NONALCOHOLIC STEATOHEPATITIS.
Conflict of interest statement
Competing interests: J-YS received grants from the Ministry of Food and Drug Safety, the Ministry of Health and Welfare, the National Research Foundation of Korea and pharmaceutical companies, including Daiichi Sankyo, GlaxoSmithKline and Pfizer, outside the submitted work.
Comment on
-
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals.Gut. 2021 May;70(5):962-969. doi: 10.1136/gutjnl-2020-322572. Epub 2020 Sep 16. Gut. 2021. PMID: 32938692
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical